Rosuvastatin 10mg Tablet - Rosuvastatin Sandoz - 1 box
Reduction of total mortality & risk of major CV events in adults with increased risk of atherosclerotic CV disease based on presence of CV disease risk markers. Primary dysbetalipoproteinemia (type III hyperlipoproteinemia); primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia & severe non-familial hypercholesterolaemia); combined (mixed) dyslipidaemia (type IIb); homozygous familial hypercholesterolaemia. Adjunctive therapy to diet to slow progression of atherosclerosis in adults as part of treatment strategy to lower total-C & LDL-C to target levels. Adjunct to diet to reduce total-C, LDL-C & ApoB levels in adolescents at least 1 years post-menarche, 10-17 years with heterozygous familial hypercholesterolaemia.
- 10mg Rosuvastatin Ca
- Individualized dosage. Usual initial dose: 10 mg once daily.
- Severe hypercholesterolemia at high CV risk Increase dose to 40 mg.
- Predisposing factors to myopathy Recommended starting dose: 5 mg. Severe renal impairment 5 mg once daily. Not to exceed 10 mg once daily.